Physician profile
Alfonso Ramirez
NPI 1730158718
$2,185.47
in general payments reported to CMS, 2019-2025
20 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $364 · 2021: $466 · 2022: $234 · 2023: $174 · 2024: $190 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.56 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $378.33 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $285.16 | 2019-2022 | |
| Pfizer INC. | $253.06 | 2019-2025 | |
| Gilead Sciences, INC. | $139.03 | 2019 | |
| Merck Sharp & Dohme LLC | $126.52 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $121.20 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $102.52 | 2021 | |
| Lilly USA, LLC | $93.70 | 2021-2025 | Jardiance |
| Exact Sciences Corporation | $74.08 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $50.19 | 2019-2025 | Repatha, Otezla, Repatha |
| Vbi Vaccine (Delaware) INC. | $40.27 | 2022-2023 | Prehevbrio |
| Abbott Laboratories | $22.90 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.82 | 2022 | |
| Hologic Sales and Service, LLC | $20.52 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19.52 | 2023 | Shingrix |
| Arbor Pharmaceuticals, INC. | $15.01 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.80 | 2020 | |
| Abbvie INC. | $14.67 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfonso Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.